The Effects of Risedronate Therapy Combined With Vitamin D and Calcium on Biochemical Markers of Bone Turnover and Bone Mineral Density in Postmenopausal Osteoporosis
The aim of the study was to investigate the effects of risedronate therapy combined with vitamin D and calcium on bone mineral density(BMD) and biochemical markers of bone turnover in patients with primary postmenopausal osteoporosis. Fifty osteoporotic postmenopausal women were included in our stud...
Saved in:
Main Authors: | Hüsniye Koç (Author), Hilal Sekban (Author), Cengiz Bahadır (Author), Nuriye Gürer (Author), Sacide Atalay (Author), Can Bora Önder (Author) |
---|---|
Format: | Book |
Published: |
Galenos Yayinevi,
2004-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Changes of bone turnover markers and bone mineral density among postmenopausal Thai women with osteoporosis receiving generic risedronate
by: Ammarin Suwan, et al.
Published: (2024) -
Once-monthly risedronate for postmenopausal osteoporosis
by: Kristina Casadei, et al.
Published: (2009) -
The Relationship Between the FRAX Tool and Bone Turnover Markers in Postmenopausal Osteoporosis
by: Murat Uludağ, et al.
Published: (2013) -
Impact of Risedronate on Bone Mineral Density and Quality of Life in Postmenopausal Women with Osteoporosis: The Results of 1-Year Follow up
by: Ercan Madenci, et al.
Published: (2003) -
The Comparison of the Effect of Risedronate and Strontium Ranelate on Bone Mineral Density in Postmenopausal Women
by: Figen Yılmaz, et al.
Published: (2012)